PAGE 5

pressures and constrained federal budgets, the ADA has experienced an increase in demand for diabetes research dollars, reflected in the steady growth in applications received each year. While increased volume results in ever higher-quality research being supported, it also presents challenges in meeting the funding demands of the diabetes research community. The Association is committed to meeting these challenges through strong stewardship of its current sup-port, developing innovative new pro-grams to address critical needs, and through careful measurement and frequent adjustments to strategies to maintain direct progress toward goals. Impact assessments will evaluate progress against the following strategic long-term metrics: By 2015 there will be an increase in ADA award recipients who receive subsequent federal funding, an increase in total federal funding for diabetes research, and an increase in ADA research funding. To support these goals, the organization will increase career de-velopment resources for ADA grant recip-ients to better enable them to successfully compete for federal research dollars, will work to attract new talent to the field, and will expand the core research program to support high-quality and innovative basic, clinical, and translational science across the full spectrum of diabetes research.The Association will continue to collect annual data to capture meaningful antecedents of successful attainment of the longer-term goals, including reten-tion and advancement of principal inves-tigators in diabetes research, peer-reviewedpublications, patents, and subsequent fed-eral funding. Using these findings, the ADA research programs can be strength-ened and modified to ensure progress toward the prevention, treatment, and ultimate cure of diabetes. The success of research is critically important to reach the Association’s stra-tegic goals. Meaningful research out-comes have and will continue to advance the field by expediting the identification of those with diabetes before the onset of complications, reducing disparities among those at high risk, ensuring the best clinical care, preventing diabetes-related mortality, and guiding the development and refine-ment of both programmatic and funding strategies. DISSEMINATION OF RESEARCH INFORMATION— Another key requirement for research progress is rapid and broad dissemination of research results throughout the research community and to the public, something the ADA is well placed to accomplish. Each year, the ADA’s annual Scientific Sessions serves as the largest meeting of diabetes researchers and clinicians in the world.